esperoct
novo nordisk a/s - turoctocog alfa πεγόλη - Αιμορροφιλία Α - Αντιαιμορραγικά - Θεραπεία και προφύλαξη αιμορραγιών σε ασθενείς 12 ετών και άνω με αιμορροφιλία Α (συγγενής ανεπάρκεια του παράγοντα viii).
octaplex 500iu powder and solvent for solution for infusion
octapharma (ip) sprl (0000010636) alle de la recherche 65, anderlecht, bruxelles - capitale, 1070 - human prothrombin complex; human protein c; protein s - powder and solvent for solution for infusion - 500iu - human prothrombin complex (0037224638) 25iu; human protein c (0060202166) 13iu; protein s (8000000170) 12iu
octanate lv 200iu/ml(1000iu/5ml) powder & solvent for solution for injection
octapharma (ip) sprl (0000010636) alle de la recherche 65, anderlecht, bruxelles - capitale, 1070 - human coagulation factor viii - powder & solvent for solution for injection - 200iu/ml(1000iu/5ml) - human coagulation factor viii (8000002372) 1000iu
octanate lv 100iu/ml(500iu/5ml) powder & solvent for solution for injection
octapharma (ip) sprl (0000010636) alle de la recherche 65, anderlecht, bruxelles - capitale, 1070 - human coagulation factor viii - powder & solvent for solution for injection - 100iu/ml(500iu/5ml) - human coagulation factor viii (8000002372) 500iu
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - Αντιαιμορραγικά - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
prothromplex total® ps.inj.sol 500 iu/vial
baxalta innovations gmbh, austria industriestrasse 67, a-1221 vienna +43 1 20 100-0 - factor ii (prothrombin); factor vii (proconvertin); factor ix (monoclonal antibody purified); factor x (stuart prower factor); human protein c - ps.inj.sol (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 500 iu/vial - factor ii (prothrombin) 375 - 708iu; factor vii (proconvertin) 417iu; factor ix (monoclonal antibody purified) 500iu; factor x (stuart prower factor) 500iu; human protein c 333iu - coagulation factor ix, ii, vii and x in combination
hemoleven ps.sol.inf 1000 u
ΙΦΕΤ ΑΕ 18ο χλμ. Λεωφ. Μαραθώνος,, 153 51 153 51, Παλλήνη Αττικής 210.6603400-6603522 - factor xi (plasma thromboplastin antecedent) - ps.sol.inf (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 1000 u - factor xi (plasma thromboplastin antecedent) - blood coagulation factors
novoseven 60 kiu/vial ly.pd.inj
novo nordisk a/s, bagsvaerd, denmark - eptacog alfa (activated) - ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ - 60 kiu/vial - ΒΙΟΛΟΓΙΚΟ ΠΡΟΙΟΝ (ΒΠ)
novoseven 120 kiu/vial ly.pd.inj
novo nordisk a/s, bagsvaerd, denmark - eptacog alfa (activated) - ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ - 120 kiu/vial - ΒΙΟΛΟΓΙΚΟ ΠΡΟΙΟΝ (ΒΠ)
novoseven 240 kiu/vial ly.pd.inj
novo nordisk a/s, bagsvaerd, denmark - eptacog alfa (activated) - ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ - 240 kiu/vial - ΒΙΟΛΟΓΙΚΟ ΠΡΟΙΟΝ (ΒΠ)